Northridge, California, United States Heritage Provider Network is the famous Corporate Investor, which was founded in 1996. The company was established in North America in United States. The main department of described Corporate Investor is located in the Northridge.
The current fund was established by Richard Merkin.
The top amount of exits for fund were in 2019. The top activity for fund was in 2018. The common things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in less than 2 investment rounds annually.
The typical case for the fund is to invest in rounds with 6-7 participants. Despite the Heritage Provider Network, startups are often financed by Cambia Health Solutions, Wilson Sonsini Goodrich & Rosati, Rising Tide. The meaningful sponsors for the fund in investment in the same round are Wilson Sonsini Goodrich & Rosati, Rising Tide, Pillar Companies. In the next rounds fund is usually obtained by Celgene, Amgen Ventures, Alexandria Real Estate Equities.
The fund has exact preference in a number of founders of portfolio startups. In case when startup counts 3 or 4 of the founder, the chance for it to get the investment is meager. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the various public portfolio startups of the fund, we may underline IDx, Celsius Therapeutics, GNS Healthcare Among the most popular fund investment industries, there are Biotechnology, Pharmaceutical. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund.
Related Funds
| Fund Name | Location |
| Aurify Brands | New York, New York, United States |
| Bracket Capital | Beverly Hills, California, United States |
| Canadian Science and Technology Growth Fund | Canada, London, Ontario |
| Comcast Spectacor | Pennsylvania, Philadelphia, United States |
| Cramer Rosenthal McGlynn LLC. | Providence, Rhode Island, United States |
| FreshDirect | Long Island City, New York, United States |
| Garnett Ventures | California, San Francisco, United States |
| Gibralt Capital Corporation | British Columbia, Canada, Vancouver |
| Gmarket | New York, New York, United States |
| Paytm Mall | India, Noida, Uttar Pradesh |
| Pecunio | Dubai, United Arab Emirates |
| Phyto Partners | Boca Raton, Florida, United States |
| Real Tech Fund | Japan, Sumida |
| Rongsheng Huitong | Beijing, China, Pinggu |
| StepStone Real Estate | - |
| Sunland Fund | China, Shanghai |
| SV-FINTECH Fund | Japan, Kanagawa Prefecture, Kawasaki |
| Tailwind Capital | New York, New York, United States |
| University Hospitals | Cleveland, Ohio, United States |
| ZHEFU Holding | China, Tonglu, Zhejiang |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Celsius Therapeutics | $83M | 24 Mar 2022 | Cambridge, Massachusetts, United States | ||
InterVenn | $201M | 02 Aug 2021 | South San Francisco, California, United States | ||
RubiconMD | $18M | 10 Mar 2020 | New York, New York, United States | ||
GRO Biosciences | $3M | 13 Mar 2019 | Boston, Massachusetts, United States | ||
Alphamab Oncology | $100M | 16 Nov 2018 | Jiangsu | ||
Glympse Bio | $22M | 09 Oct 2018 | Cambridge, Massachusetts, United States | ||
| $32M | 27 Sep 2018 | Iowa, United States | |||
Celsius Therapeutics | $65M | 15 May 2018 | Cambridge, Massachusetts, United States | ||
GRO Biosciences | $2M | 08 Feb 2018 | Boston, Massachusetts, United States |
– InterVenn Biosciences announced the completion of a $201m Series C financing.
– The funding round was led by new investors SoftBank Group, Heritage Provider Network, Irving Investors, Highside Capital Management, and backed by existing investors Amplify Partners, Anzu Partners, Genoa Ventures and True Ventures.
– The proceeds from the financing will be used to accelerate development and commercialization of Dawn, the company’s liquid biopsy assay for immune checkpoint inhibitor response prediction, and to expand the network of partners on the company’s AI-driven glycoproteomics platform.
– To date, the InterVenn glycoproteomics platform has been used to develop 16 clinical use cases across oncology and other indications. Dawn is currently under development and is planned to be commercialized in 2022.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Celsius Therapeutics | $83M | 24 Mar 2022 | Cambridge, Massachusetts, United States | ||
InterVenn | $201M | 02 Aug 2021 | South San Francisco, California, United States | ||
RubiconMD | $18M | 10 Mar 2020 | New York, New York, United States | ||
GRO Biosciences | $3M | 13 Mar 2019 | Boston, Massachusetts, United States | ||
Alphamab Oncology | $100M | 16 Nov 2018 | Jiangsu | ||
Glympse Bio | $22M | 09 Oct 2018 | Cambridge, Massachusetts, United States | ||
| $32M | 27 Sep 2018 | Iowa, United States | |||
Celsius Therapeutics | $65M | 15 May 2018 | Cambridge, Massachusetts, United States | ||
GRO Biosciences | $2M | 08 Feb 2018 | Boston, Massachusetts, United States |
